An at-home, non-invasive screening for cervical pre-cancer could increase compliance with recommended follow-up tests, according to research presented recently at a cancer conference.
The new screening, called the S5 test, is based on a urine sample or a vaginal swab that women can collect themselves at home and have sent to a lab.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
